ASCLERA: payments to doctors
Payments that named ASCLERA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $625K
- Providers
- 2,656
- Transactions
- 7,497
- Average per transaction
- $83
The per-transaction average — $83 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,656 providers the average total is $235, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merz North America, Inc. | $478,955 | 76.7% |
| MERZ North America, Inc. | $135,766 | 21.7% |
| Angiodynamics, Inc. | $9,830 | 1.6% |